CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishBRUSA, GIANLUCA
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 1 | The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene | MANCINI M; BRUSA G; BENVENUTI M; MAZZACURATI L; CAMPANINI F; BARBIERI E; CAMMELLI S; CALONGHI N; MARTINELLI G; BACCARANI M.; SANTUCCI MA | 2004 | LEUKEMIA | 1.01 Articolo in rivista | |
| 2 | The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein | Mancini M.; Zuffa E.; Corrado P.; Pagnotta E.; Brusa G.; Corradi V.; martinelli G.; Barbieri E.; Santucci M.A. | 2007 | s.n | 4.02 Riassunto (Abstract) | |
| 3 | Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies | Corrado P.; Brusa G.; Mancini M.; Zuffa E.; Corradi V.; Martinelli G.; Barbieri E.; Santucci M.A. | 2007 | s.n | 4.02 Riassunto (Abstract) | |
| 4 | Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 | Mancini M; Brusa G; Zuffa E; Corrado P; Martinelli G; Grafone T; Barbieri E; Santucci MA | 2007 | LEUKEMIA RESEARCH | 1.01 Articolo in rivista | |
| 5 | P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes | M. Mancini; N. Calonghi; E. Pagnotta; L. Masotti; G. Brusa; E. Zuffa; A. Calabrò; E. Barbieri; M. A. Santucci | 2005 | GENE THERAPY & MOLECULAR BIOLOGY | 1.01 Articolo in rivista | |
| 6 | P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors | Brusa G; Zuffa E; Mancini M; Benvenuti M; Calonghi N; Barbieri E; Santucci MA. | 2006 | BRITISH JOURNAL OF HAEMATOLOGY | 1.01 Articolo in rivista | |
| 7 | NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE | M. Mancini; G. Brusa; E. Zuffa; T. Graffone; F. Pennisi; N. Calonghi; L. Masotti; M. A. Santucci | 2005 | Tipografia Senese | 4.01 Contributo in Atti di convegno | |
| 8 | Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells | Calonghi N; Pagnotta E; Parolin C; Molinari C; Boga C; Dal Piaz F; Brusa GL; Santucci MA; Masotti L. | 2007 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1.01 Articolo in rivista | |
| 9 | IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia | Mancini M; Zuffa E; Veljkovic N; Brusa G; Corrado P; Corradi V; Martinelli G; Barbieri E; Santucci MA. | 2008 | BRITISH JOURNAL OF HAEMATOLOGY | 1.01 Articolo in rivista | |
| 10 | HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia | Brusa G.; Mancini M.; Zuffa E.; Santucci M.A. | 2005 | s.n | 4.01 Contributo in Atti di convegno | |
| 11 | GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) | Brusa G.; Hattinger C.; Serra M.; Astolfi A.; Saponaro M.; Cammelli S.; Santucci M.A.; Barbieri E. | 2004 | Mario Cazzola | 4.01 Contributo in Atti di convegno | |
| 12 | Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma | Brusa G.; Zuffa E.; Remondini D.; Castellani G.; Serra M.; Hattinger C.M.; Morandi L.; Zinzani P.L.; Mancini M.; Corrado P.; Barbieri E.; Santucci M.A. | 2007 | s.n | 4.02 Riassunto (Abstract) | |
| 13 | Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. | Brusa G; Zuffa E; Hattinger CM; Serra M; Remondini D; Castellani G; Righi S; Campidelli C; Pileri S; Zinzani PL; Gabriele A; Mancini M; Corrado P; Barbieri E; Santucci MA. | 2007 | ONCOLOGY REPORTS | 1.01 Articolo in rivista | |
| 14 | Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. | PATTACINI L; MANCINI M; MAZZACURATI L; BRUSA G; BENVENUTI M; MARTINELLI G.; BACCARANI M; SANTUCCI MA. | 2004 | LEUKEMIA RESEARCH | 1.01 Articolo in rivista | |
| 15 | Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) | M. Mancini; G. Brusa; A. Calabrò; N. Calonghi; E. Pagnotta; M. Alessandra Santucci; L. Masotti | 2004 | Graphital | 4.01 Contributo in Atti di convegno | |
| 16 | COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE | Brusa G.; Parisi D.; Calonghi N.; Calabrò A.; Mancini M.; Zuffa E.; Arcangeli E.; Santucci M.A. | 2004 | Mario Cazzola | 4.01 Contributo in Atti di convegno | |
| 17 | CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 | MAZZACURATI L; PATTACINI L; BRUSA G; MANCINI M; BENVENUTI M; BARBIERI E; MARTINELLI G.; BACCARANI M; GREENBERGER JS; SANTUCCI MA | 2004 | HEMATOLOGY JOURNAL | 1.01 Articolo in rivista | |
| 18 | Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl | Mancini M.; Zuffa E.; Corrado P.; Brusa G.; Petta S.; Pagnotta E.; Santucci M.A. | 2006 | s.n | 4.02 Riassunto (Abstract) | |
| 19 | Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia | Corrado P; Mancini M; Brusa G; Petta S; Martinelli G; Barbieri E; Santucci MA | 2009 | LEUKEMIA | 1.01 Articolo in rivista |
Nome completo:
BRUSA, GIANLUCA
Varianti:
BRUSA G.L.
BRUSA G
G. BRUSA
BRUSA G
G. BRUSA
Copyright © 2019